Tim Lohoff

Tim is an Associate at Forbion and joined the investment team in February 2022 in the Munich office. Prior to Forbion, Tim worked for L.E.K. Consulting as a Life Sciences Specialist.

In 2021, he received his Ph.D. in Stem Cell Biology & Medicine from the University of Cambridge, where he investigated the epigenetic and transcriptional regulation of stem cell differentiation in health and disease by using and developing novel single-cell multi-omics sequencing technologies. Tim published research in multiple leading journals, including Nature, Nature Biotechnology, Nature Genetics, and Cell Stem Cell. Whilst his studies, Tim was involved in the organization of GapSummit 2018, the world’s first intergenerational biotech leadership forum that connected industry leaders with the next generation of biotech pioneers.

Tim also completed his MSc in Regenerative Biology and Medicine from the TU Dresden and a BSc in Molecular Cell Biology from the University of Bielefeld.